David E Gerber
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas (NCT03808558) | David E Gerber | 2019-09-11 |
Track David E Gerber automatically
Every clearance here is in the API, with alerts when new ones post.